| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.00e-05 | 303 | 20 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.89e-04 | 562 | 20 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.52e-04 | 140 | 20 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | lncRNA binding | 5.56e-04 | 35 | 20 | 2 | GO:0106222 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.68e-04 | 739 | 20 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.97e-04 | 417 | 20 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | 7.28e-04 | 753 | 20 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.37e-03 | 55 | 20 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.43e-03 | 875 | 20 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.64e-03 | 1356 | 20 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.85e-03 | 64 | 20 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 20 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.39e-03 | 1459 | 20 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | p53 binding | 2.67e-03 | 77 | 20 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.31e-03 | 86 | 20 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 4.28e-03 | 98 | 20 | 2 | GO:0048306 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.46e-03 | 339 | 20 | 3 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.89e-03 | 1160 | 20 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.57e-03 | 1244 | 20 | 5 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.19e-03 | 1271 | 20 | 5 | GO:0000987 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 8.89e-03 | 143 | 20 | 2 | GO:0017124 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.20e-02 | 167 | 20 | 2 | GO:0031490 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.61e-05 | 1390 | 19 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition | 3.14e-05 | 203 | 19 | 4 | GO:0001837 | |
| GeneOntologyBiologicalProcess | hexose mediated signaling | 4.40e-05 | 11 | 19 | 2 | GO:0009757 | |
| GeneOntologyBiologicalProcess | glucose mediated signaling pathway | 4.40e-05 | 11 | 19 | 2 | GO:0010255 | |
| GeneOntologyBiologicalProcess | sugar mediated signaling pathway | 4.40e-05 | 11 | 19 | 2 | GO:0010182 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 5.75e-05 | 237 | 19 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | carbohydrate mediated signaling | 6.23e-05 | 13 | 19 | 2 | GO:0009756 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 6.24e-05 | 242 | 19 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.36e-04 | 296 | 19 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.59e-04 | 1399 | 19 | 7 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.69e-04 | 1413 | 19 | 7 | GO:1902679 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition | 2.20e-04 | 130 | 19 | 3 | GO:0010717 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.26e-04 | 338 | 19 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 2.46e-04 | 135 | 19 | 3 | GO:0042752 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.51e-04 | 136 | 19 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.67e-04 | 1053 | 19 | 6 | GO:0000122 | |
| GeneOntologyBiologicalProcess | rhythmic process | 2.87e-04 | 360 | 19 | 4 | GO:0048511 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 3.22e-04 | 148 | 19 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 3.22e-04 | 148 | 19 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 3.26e-04 | 372 | 19 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 3.78e-04 | 713 | 19 | 5 | GO:0048598 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 4.70e-04 | 35 | 19 | 2 | GO:0035116 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 5.35e-04 | 176 | 19 | 3 | GO:0007224 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 6.19e-04 | 185 | 19 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 6.19e-04 | 185 | 19 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 6.77e-04 | 42 | 19 | 2 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 6.77e-04 | 42 | 19 | 2 | GO:0060487 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 6.89e-04 | 192 | 19 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 7.21e-04 | 195 | 19 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 8.48e-04 | 47 | 19 | 2 | GO:1902175 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 9.21e-04 | 49 | 19 | 2 | GO:0035137 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 9.59e-04 | 50 | 19 | 2 | GO:0006356 | |
| GeneOntologyBiologicalProcess | embryonic axis specification | 1.04e-03 | 52 | 19 | 2 | GO:0000578 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.07e-03 | 896 | 19 | 5 | GO:0006325 | |
| GeneOntologyBiologicalProcess | limb development | 1.08e-03 | 224 | 19 | 3 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.08e-03 | 224 | 19 | 3 | GO:0048736 | |
| GeneOntologyBiologicalProcess | head development | 1.20e-03 | 919 | 19 | 5 | GO:0060322 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial to mesenchymal transition | 1.20e-03 | 56 | 19 | 2 | GO:0010719 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 1.42e-03 | 61 | 19 | 2 | GO:0060428 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.44e-03 | 248 | 19 | 3 | GO:0007623 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.74e-03 | 999 | 19 | 5 | GO:0071824 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to oxidative stress | 1.77e-03 | 68 | 19 | 2 | GO:0008631 | |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification | 1.77e-03 | 68 | 19 | 2 | GO:0009948 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.96e-03 | 276 | 19 | 3 | GO:0007179 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 2.09e-03 | 74 | 19 | 2 | GO:0042733 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.17e-03 | 619 | 19 | 4 | GO:0002009 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 2.37e-03 | 79 | 19 | 2 | GO:0006360 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.37e-03 | 79 | 19 | 2 | GO:0000380 | |
| GeneOntologyBiologicalProcess | DNA repair | 2.57e-03 | 648 | 19 | 4 | GO:0006281 | |
| GeneOntologyBiologicalProcess | endoderm development | 2.94e-03 | 88 | 19 | 2 | GO:0007492 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 3.09e-03 | 324 | 19 | 3 | GO:0006302 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 3.14e-03 | 91 | 19 | 2 | GO:0048663 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.14e-03 | 91 | 19 | 2 | GO:0003281 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 3.14e-03 | 91 | 19 | 2 | GO:0009880 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 3.20e-03 | 92 | 19 | 2 | GO:0045661 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 3.34e-03 | 333 | 19 | 3 | GO:0002218 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 3.34e-03 | 94 | 19 | 2 | GO:0003151 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.41e-03 | 95 | 19 | 2 | GO:2000781 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.42e-03 | 336 | 19 | 3 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 3.62e-03 | 343 | 19 | 3 | GO:0071559 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 3.70e-03 | 99 | 19 | 2 | GO:0051145 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.74e-03 | 347 | 19 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 3.79e-03 | 1194 | 19 | 5 | GO:0000902 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 4.15e-03 | 105 | 19 | 2 | GO:0008589 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 4.30e-03 | 107 | 19 | 2 | GO:0009953 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.34e-03 | 750 | 19 | 4 | GO:0048729 | |
| GeneOntologyBiologicalProcess | DNA recombination | 4.41e-03 | 368 | 19 | 3 | GO:0006310 | |
| GeneOntologyCellularComponent | paraspeckles | 8.95e-08 | 10 | 20 | 3 | GO:0042382 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.30e-07 | 596 | 20 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear matrix | 8.59e-06 | 140 | 20 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.89e-05 | 171 | 20 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | kinetochore | 2.36e-05 | 181 | 20 | 4 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.04e-05 | 193 | 20 | 4 | GO:0000779 | |
| GeneOntologyCellularComponent | nBAF complex | 1.04e-04 | 16 | 20 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.15e-04 | 272 | 20 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.22e-04 | 276 | 20 | 4 | GO:0000775 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.84e-04 | 307 | 20 | 4 | GO:0000793 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.92e-04 | 1377 | 20 | 7 | GO:0140513 | |
| GeneOntologyCellularComponent | chromatin | 3.00e-04 | 1480 | 20 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | fibrillar center | 4.23e-04 | 156 | 20 | 3 | GO:0001650 | |
| GeneOntologyCellularComponent | chromosomal region | 6.08e-04 | 421 | 20 | 4 | GO:0098687 | |
| GeneOntologyCellularComponent | nuclear body | 1.34e-03 | 903 | 20 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.76e-03 | 96 | 20 | 2 | GO:0070603 | |
| HumanPheno | Anterior pituitary hypoplasia | 1.77e-05 | 36 | 8 | 3 | HP:0010627 | |
| HumanPheno | Anterior pituitary dysgenesis | 2.26e-05 | 39 | 8 | 3 | HP:0010625 | |
| HumanPheno | Deviated nasal septum | 4.52e-05 | 7 | 8 | 2 | HP:0004411 | |
| HumanPheno | Narrow nasal bridge | 5.74e-05 | 53 | 8 | 3 | HP:0000446 | |
| HumanPheno | Dysplastic corpus callosum | 1.26e-04 | 395 | 8 | 5 | HP:0006989 | |
| Domain | NOPS | 3.27e-06 | 3 | 20 | 2 | PF08075 | |
| Domain | NOPS | 3.27e-06 | 3 | 20 | 2 | IPR012975 | |
| Domain | RRM_1 | 6.30e-05 | 208 | 20 | 4 | PF00076 | |
| Domain | RRM | 7.42e-05 | 217 | 20 | 4 | SM00360 | |
| Domain | RRM_dom | 8.84e-05 | 227 | 20 | 4 | IPR000504 | |
| Domain | RRM | 9.30e-05 | 230 | 20 | 4 | PS50102 | |
| Domain | - | 1.17e-04 | 244 | 20 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.45e-04 | 258 | 20 | 4 | IPR012677 | |
| Domain | Bromodomain_CS | 3.49e-04 | 26 | 20 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 7.09e-04 | 37 | 20 | 2 | PS00633 | |
| Domain | Bromodomain | 7.48e-04 | 38 | 20 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 8.71e-04 | 41 | 20 | 2 | PS50014 | |
| Domain | BROMO | 9.14e-04 | 42 | 20 | 2 | SM00297 | |
| Domain | Bromodomain | 9.14e-04 | 42 | 20 | 2 | IPR001487 | |
| Domain | - | 9.14e-04 | 42 | 20 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.35e-05 | 137 | 18 | 4 | M48232 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 5.43e-05 | 59 | 18 | 3 | M39579 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.98e-04 | 91 | 18 | 3 | M27101 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.19e-04 | 21 | 18 | 2 | M39593 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.50e-04 | 22 | 18 | 2 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.18e-04 | 24 | 18 | 2 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.91e-04 | 26 | 18 | 2 | MM14793 | |
| Pathway | WP_MRNA_PROCESSING | 5.16e-04 | 126 | 18 | 3 | M39406 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 8.43e-04 | 34 | 18 | 2 | M39771 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.29e-03 | 42 | 18 | 2 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.29e-03 | 42 | 18 | 2 | M17541 | |
| Pathway | PID_HNF3A_PATHWAY | 1.41e-03 | 44 | 18 | 2 | M285 | |
| Pathway | PID_HNF3B_PATHWAY | 1.48e-03 | 45 | 18 | 2 | M106 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.68e-03 | 48 | 18 | 2 | M219 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 1.89e-03 | 51 | 18 | 2 | M48267 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.99e-03 | 201 | 18 | 3 | M39605 | |
| Pathway | WP_MRNA_PROCESSING | 2.21e-03 | 451 | 18 | 4 | MM15946 | |
| Pubmed | hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. | 1.63e-10 | 3 | 20 | 3 | 19874820 | |
| Pubmed | 1.87e-09 | 29 | 20 | 4 | 19279220 | ||
| Pubmed | 2.83e-09 | 32 | 20 | 4 | 31815296 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.54e-09 | 444 | 20 | 7 | 34795231 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.32e-09 | 457 | 20 | 7 | 32344865 | |
| Pubmed | 7.69e-09 | 803 | 20 | 8 | 36517590 | ||
| Pubmed | 9.09e-09 | 8 | 20 | 3 | 18042045 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.28e-08 | 582 | 20 | 7 | 20467437 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.93e-08 | 954 | 20 | 8 | 36373674 | |
| Pubmed | 4.26e-08 | 638 | 20 | 7 | 33239621 | ||
| Pubmed | 1.10e-07 | 17 | 20 | 3 | 21924257 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.39e-07 | 220 | 20 | 5 | 35785414 | |
| Pubmed | 2.32e-07 | 244 | 20 | 5 | 29884807 | ||
| Pubmed | TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. | 2.49e-07 | 22 | 20 | 3 | 17803295 | |
| Pubmed | 2.86e-07 | 23 | 20 | 3 | 21670149 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 25765647 | ||
| Pubmed | Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism. | 3.14e-07 | 2 | 20 | 2 | 35886974 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 27924002 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 15590677 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 12417296 | ||
| Pubmed | Purification and characterization of a DNA-binding heterodimer of 52 and 100 kDa from HeLa cells. | 3.14e-07 | 2 | 20 | 2 | 8439294 | |
| Pubmed | The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha. | 3.14e-07 | 2 | 20 | 2 | 17965020 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 25605962 | ||
| Pubmed | PSF/p54(nrb) stimulates "jumping" of DNA topoisomerase I between separate DNA helices. | 3.14e-07 | 2 | 20 | 2 | 10858305 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 12944487 | ||
| Pubmed | Promoter-Dependent Translation Controlled by p54nrb and hnRNPM during Myoblast Differentiation. | 3.14e-07 | 2 | 20 | 2 | 26332123 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.90e-07 | 271 | 20 | 5 | 32433965 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 3.95e-07 | 107 | 20 | 4 | 20508642 | |
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 5.28e-07 | 28 | 20 | 3 | 19596686 | |
| Pubmed | 7.98e-07 | 32 | 20 | 3 | 19542561 | ||
| Pubmed | 7.98e-07 | 32 | 20 | 3 | 36252997 | ||
| Pubmed | 8.89e-07 | 131 | 20 | 4 | 34551306 | ||
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | 9.26e-07 | 323 | 20 | 5 | 25959826 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 9.42e-07 | 3 | 20 | 2 | 14716005 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18682709 | ||
| Pubmed | P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. | 9.42e-07 | 3 | 20 | 2 | 16148043 | |
| Pubmed | Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-interacting proteins. | 9.42e-07 | 3 | 20 | 2 | 18655028 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 16641145 | ||
| Pubmed | Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins. | 9.42e-07 | 3 | 20 | 2 | 22213094 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 15790595 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 16467360 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 30445466 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11713256 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 25326457 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 17639083 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 19906647 | ||
| Pubmed | Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. | 9.42e-07 | 3 | 20 | 2 | 20421735 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 9393982 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 36595695 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11525732 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 9.62e-07 | 34 | 20 | 3 | 30894540 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.04e-06 | 1024 | 20 | 7 | 24711643 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.14e-06 | 1038 | 20 | 7 | 26673895 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.32e-06 | 1061 | 20 | 7 | 33845483 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.39e-06 | 351 | 20 | 5 | 38297188 | |
| Pubmed | 1.41e-06 | 660 | 20 | 6 | 32780723 | ||
| Pubmed | 1.57e-06 | 151 | 20 | 4 | 18457437 | ||
| Pubmed | 1.65e-06 | 153 | 20 | 4 | 28225217 | ||
| Pubmed | 1.71e-06 | 1103 | 20 | 7 | 34189442 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 27259250 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 32764370 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 12509444 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 15449938 | ||
| Pubmed | The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction. | 1.88e-06 | 4 | 20 | 2 | 9756848 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 33581550 | ||
| Pubmed | 1.92e-06 | 159 | 20 | 4 | 22751105 | ||
| Pubmed | 1.98e-06 | 43 | 20 | 3 | 26030138 | ||
| Pubmed | 2.10e-06 | 707 | 20 | 6 | 19738201 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 2.51e-06 | 170 | 20 | 4 | 16159877 | |
| Pubmed | 2.63e-06 | 172 | 20 | 4 | 26336360 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.01e-06 | 411 | 20 | 5 | 35182466 | |
| Pubmed | 3.04e-06 | 754 | 20 | 6 | 35906200 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 17452459 | ||
| Pubmed | Dynamic paraspeckle component localisation during spermatogenesis. | 3.14e-06 | 5 | 20 | 2 | 31299635 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 15870273 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 11003650 | ||
| Pubmed | The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity. | 3.14e-06 | 5 | 20 | 2 | 21819346 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 11897684 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 17507659 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 8813084 | ||
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 3.14e-06 | 5 | 20 | 2 | 32808927 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 23321477 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 30475207 | ||
| Pubmed | Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. | 3.14e-06 | 5 | 20 | 2 | 16806149 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 12810069 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 17220277 | ||
| Pubmed | Distinct roles of DBHS family members in the circadian transcriptional feedback loop. | 3.14e-06 | 5 | 20 | 2 | 22966205 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 28846091 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 19448667 | ||
| Pubmed | 3.31e-06 | 419 | 20 | 5 | 15635413 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 4.06e-06 | 1257 | 20 | 7 | 36526897 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.50e-06 | 807 | 20 | 6 | 22681889 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.50e-06 | 807 | 20 | 6 | 30575818 | |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 4.71e-06 | 6 | 20 | 2 | 11076796 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 30423030 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 11259580 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 19389484 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 31175693 | ||
| Pubmed | 4.84e-06 | 453 | 20 | 5 | 29656893 | ||
| Pubmed | 6.32e-06 | 63 | 20 | 3 | 37052853 | ||
| Interaction | NUP35 interactions | 3.63e-09 | 424 | 20 | 8 | int:NUP35 | |
| Interaction | NKX2-1 interactions | 1.63e-08 | 180 | 20 | 6 | int:NKX2-1 | |
| Interaction | ERG interactions | 5.84e-08 | 223 | 20 | 6 | int:ERG | |
| Interaction | EWSR1 interactions | 7.74e-08 | 906 | 20 | 9 | int:EWSR1 | |
| Interaction | AR interactions | 1.68e-07 | 992 | 20 | 9 | int:AR | |
| Interaction | SMARCA4 interactions | 1.90e-07 | 462 | 20 | 7 | int:SMARCA4 | |
| Interaction | YAP1 interactions | 3.89e-07 | 1095 | 20 | 9 | int:YAP1 | |
| Interaction | RUNX1 interactions | 5.28e-07 | 324 | 20 | 6 | int:RUNX1 | |
| Interaction | NONO interactions | 6.10e-07 | 549 | 20 | 7 | int:NONO | |
| Interaction | MIR29B2 interactions | 6.57e-07 | 71 | 20 | 4 | int:MIR29B2 | |
| Interaction | MIR29B1 interactions | 7.35e-07 | 73 | 20 | 4 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 7.76e-07 | 74 | 20 | 4 | int:MIR20A | |
| Interaction | MIR15A interactions | 8.19e-07 | 75 | 20 | 4 | int:MIR15A | |
| Interaction | MIR429 interactions | 8.64e-07 | 76 | 20 | 4 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 9.11e-07 | 77 | 20 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 9.11e-07 | 77 | 20 | 4 | int:MIR200A | |
| Interaction | MIR31 interactions | 1.29e-06 | 84 | 20 | 4 | int:MIR31 | |
| Interaction | MIR17 interactions | 1.36e-06 | 85 | 20 | 4 | int:MIR17 | |
| Interaction | MIR93 interactions | 1.36e-06 | 85 | 20 | 4 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 1.36e-06 | 85 | 20 | 4 | int:MIR9-1 | |
| Interaction | MIR20B interactions | 1.42e-06 | 86 | 20 | 4 | int:MIR20B | |
| Interaction | SP100 interactions | 1.45e-06 | 206 | 20 | 5 | int:SP100 | |
| Interaction | GSC interactions | 1.49e-06 | 87 | 20 | 4 | int:GSC | |
| Interaction | XRCC6 interactions | 1.51e-06 | 928 | 20 | 8 | int:XRCC6 | |
| Interaction | MIR141 interactions | 1.56e-06 | 88 | 20 | 4 | int:MIR141 | |
| Interaction | PML interactions | 1.57e-06 | 933 | 20 | 8 | int:PML | |
| Interaction | MIR29C interactions | 1.63e-06 | 89 | 20 | 4 | int:MIR29C | |
| Interaction | MIR221 interactions | 1.71e-06 | 90 | 20 | 4 | int:MIR221 | |
| Interaction | MIR19B2 interactions | 2.03e-06 | 94 | 20 | 4 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 2.03e-06 | 94 | 20 | 4 | int:MIRLET7F1 | |
| Interaction | TOPORS interactions | 2.21e-06 | 96 | 20 | 4 | int:TOPORS | |
| Interaction | MIR21 interactions | 2.30e-06 | 97 | 20 | 4 | int:MIR21 | |
| Interaction | MIR363 interactions | 2.30e-06 | 97 | 20 | 4 | int:MIR363 | |
| Interaction | MIR128-2 interactions | 2.50e-06 | 99 | 20 | 4 | int:MIR128-2 | |
| Interaction | SMC5 interactions | 2.64e-06 | 1000 | 20 | 8 | int:SMC5 | |
| Interaction | MIRLET7B interactions | 2.71e-06 | 101 | 20 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 2.71e-06 | 101 | 20 | 4 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 2.71e-06 | 101 | 20 | 4 | int:MIR25 | |
| Interaction | STIP1 interactions | 2.76e-06 | 1006 | 20 | 8 | int:STIP1 | |
| Interaction | MIRLET7A3 interactions | 2.82e-06 | 102 | 20 | 4 | int:MIRLET7A3 | |
| Interaction | CTNNB1 interactions | 2.82e-06 | 1009 | 20 | 8 | int:CTNNB1 | |
| Interaction | MIR34A interactions | 3.04e-06 | 104 | 20 | 4 | int:MIR34A | |
| Interaction | MIR19B1 interactions | 3.04e-06 | 104 | 20 | 4 | int:MIR19B1 | |
| Interaction | MIRLET7E interactions | 3.28e-06 | 106 | 20 | 4 | int:MIRLET7E | |
| Interaction | MIR34B interactions | 3.81e-06 | 110 | 20 | 4 | int:MIR34B | |
| Interaction | CEBPB interactions | 3.93e-06 | 1443 | 20 | 9 | int:CEBPB | |
| Interaction | CUL4B interactions | 4.01e-06 | 728 | 20 | 7 | int:CUL4B | |
| Interaction | MIRLET7I interactions | 4.39e-06 | 114 | 20 | 4 | int:MIRLET7I | |
| Interaction | MIRLET7G interactions | 4.87e-06 | 117 | 20 | 4 | int:MIRLET7G | |
| Interaction | SCARNA22 interactions | 5.03e-06 | 118 | 20 | 4 | int:SCARNA22 | |
| Interaction | NANOG interactions | 5.23e-06 | 481 | 20 | 6 | int:NANOG | |
| Interaction | LINC00624 interactions | 7.47e-06 | 39 | 20 | 3 | int:LINC00624 | |
| Interaction | CELF1 interactions | 7.49e-06 | 288 | 20 | 5 | int:CELF1 | |
| Interaction | NCOA1 interactions | 1.17e-05 | 146 | 20 | 4 | int:NCOA1 | |
| Interaction | HDAC2 interactions | 1.24e-05 | 865 | 20 | 7 | int:HDAC2 | |
| Interaction | CYLD interactions | 1.27e-05 | 868 | 20 | 7 | int:CYLD | |
| Interaction | SFPQ interactions | 1.28e-05 | 563 | 20 | 6 | int:SFPQ | |
| Interaction | CEBPA interactions | 1.34e-05 | 1245 | 20 | 8 | int:CEBPA | |
| Interaction | MYEF2 interactions | 1.37e-05 | 152 | 20 | 4 | int:MYEF2 | |
| Interaction | SLX4 interactions | 1.41e-05 | 572 | 20 | 6 | int:SLX4 | |
| Interaction | SMARCA2 interactions | 1.82e-05 | 346 | 20 | 5 | int:SMARCA2 | |
| Interaction | SMARCB1 interactions | 2.32e-05 | 364 | 20 | 5 | int:SMARCB1 | |
| Interaction | PITX3 interactions | 2.61e-05 | 8 | 20 | 2 | int:PITX3 | |
| Interaction | NR3C1 interactions | 2.68e-05 | 974 | 20 | 7 | int:NR3C1 | |
| Interaction | SMARCC1 interactions | 3.00e-05 | 384 | 20 | 5 | int:SMARCC1 | |
| Interaction | EP300 interactions | 3.16e-05 | 1401 | 20 | 8 | int:EP300 | |
| Interaction | PLEKHF2 interactions | 3.30e-05 | 190 | 20 | 4 | int:PLEKHF2 | |
| Interaction | PAN2 interactions | 3.51e-05 | 397 | 20 | 5 | int:PAN2 | |
| Interaction | SOX2 interactions | 3.52e-05 | 1422 | 20 | 8 | int:SOX2 | |
| Interaction | FXR1 interactions | 3.70e-05 | 679 | 20 | 6 | int:FXR1 | |
| Interaction | NUPR1 interactions | 3.82e-05 | 683 | 20 | 6 | int:NUPR1 | |
| Interaction | TADA2A interactions | 3.87e-05 | 198 | 20 | 4 | int:TADA2A | |
| Interaction | TAF15 interactions | 4.00e-05 | 408 | 20 | 5 | int:TAF15 | |
| Interaction | MIR138-1 interactions | 4.02e-05 | 68 | 20 | 3 | int:MIR138-1 | |
| Interaction | GATA4 interactions | 4.15e-05 | 411 | 20 | 5 | int:GATA4 | |
| Interaction | ONECUT1 interactions | 4.19e-05 | 10 | 20 | 2 | int:ONECUT1 | |
| Interaction | DDB1 interactions | 4.29e-05 | 697 | 20 | 6 | int:DDB1 | |
| Interaction | SMARCA5 interactions | 4.34e-05 | 415 | 20 | 5 | int:SMARCA5 | |
| Interaction | MIR9-3 interactions | 4.39e-05 | 70 | 20 | 3 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 4.58e-05 | 71 | 20 | 3 | int:MIR140 | |
| Interaction | MIR122 interactions | 4.58e-05 | 71 | 20 | 3 | int:MIR122 | |
| Interaction | SON interactions | 4.69e-05 | 208 | 20 | 4 | int:SON | |
| Interaction | SEC16A interactions | 4.92e-05 | 426 | 20 | 5 | int:SEC16A | |
| Interaction | MIR18A interactions | 4.97e-05 | 73 | 20 | 3 | int:MIR18A | |
| Interaction | NR4A1 interactions | 5.05e-05 | 212 | 20 | 4 | int:NR4A1 | |
| Interaction | DUX4 interactions | 5.24e-05 | 214 | 20 | 4 | int:DUX4 | |
| Interaction | HDAC5 interactions | 5.26e-05 | 432 | 20 | 5 | int:HDAC5 | |
| Interaction | MIR16-1 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR199A2 | |
| Interaction | MIR7-3 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR7-3 | |
| Interaction | MIR92A1 interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR451A | |
| Interaction | MIR98 interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR98 | |
| Interaction | PRPF40A interactions | 6.11e-05 | 446 | 20 | 5 | int:PRPF40A | |
| Interaction | HDAC1 interactions | 6.13e-05 | 1108 | 20 | 7 | int:HDAC1 | |
| Interaction | RARA interactions | 6.15e-05 | 223 | 20 | 4 | int:RARA | |
| Interaction | MIR222 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR222 | |
| Interaction | MIR206 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR34C | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 7.20e-03 | 294 | 20 | 2 | chr1p34 | |
| GeneFamily | RNA binding motif containing | 1.23e-05 | 213 | 13 | 4 | 725 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.23e-03 | 181 | 13 | 2 | 694 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 1.85e-05 | 213 | 20 | 4 | M14601 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 5.77e-05 | 15 | 20 | 2 | M9138 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 7.42e-05 | 304 | 20 | 4 | M39208 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 7.52e-05 | 305 | 20 | 4 | M40025 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 9.35e-05 | 634 | 20 | 5 | M40866 | |
| Coexpression | SEIDEN_MET_SIGNALING | 1.04e-04 | 20 | 20 | 2 | M16468 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_BCELL_DN | 1.95e-04 | 150 | 20 | 3 | M6755 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN | 1.95e-04 | 150 | 20 | 3 | M6749 | |
| Coexpression | HSIAO_HOUSEKEEPING_GENES | 2.07e-04 | 397 | 20 | 4 | M11197 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 2.30e-04 | 408 | 20 | 4 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 2.45e-04 | 415 | 20 | 4 | MM1028 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 2.61e-04 | 790 | 20 | 5 | M12490 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 2.71e-04 | 32 | 20 | 2 | MM668 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 2.71e-04 | 32 | 20 | 2 | M1558 | |
| Coexpression | ZHANG_UTERUS_C7_EPITHELIAL2_CELL | 2.75e-04 | 799 | 20 | 5 | MM16613 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP | 2.88e-04 | 33 | 20 | 2 | M41050 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | 4.40e-04 | 484 | 20 | 4 | M14665 | |
| Coexpression | GSE27786_BCELL_VS_CD8_TCELL_DN | 4.47e-04 | 199 | 20 | 3 | M4802 | |
| Coexpression | GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN | 4.53e-04 | 200 | 20 | 3 | M4136 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 4.53e-04 | 200 | 20 | 3 | M3277 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 4.53e-04 | 200 | 20 | 3 | M4016 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 4.53e-04 | 200 | 20 | 3 | M6611 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 4.53e-04 | 200 | 20 | 3 | M5781 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 4.88e-04 | 905 | 20 | 5 | M40865 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL | 5.09e-04 | 503 | 20 | 4 | M41690 | |
| Coexpression | LUI_THYROID_CANCER_PAX8_PPARG_UP | 5.61e-04 | 46 | 20 | 2 | M4381 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 6.87e-04 | 545 | 20 | 4 | MM3785 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_1 | 7.17e-04 | 52 | 20 | 2 | M2135 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 2.68e-05 | 66 | 19 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 5.54e-05 | 815 | 19 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_200 | 1.02e-04 | 17 | 19 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200 | 2.25e-04 | 25 | 19 | 2 | gudmap_developingGonad_e14.5_ epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.08e-04 | 150 | 19 | 3 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.46e-04 | 156 | 19 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.95e-04 | 403 | 19 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 4.06e-04 | 406 | 19 | 4 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 4.06e-04 | 406 | 19 | 4 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.34e-04 | 413 | 19 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 4.50e-04 | 417 | 19 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.42e-04 | 182 | 19 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 5.45e-04 | 795 | 19 | 5 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.64e-04 | 801 | 19 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 5.74e-04 | 804 | 19 | 5 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 5.80e-04 | 40 | 19 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 5.80e-04 | 806 | 19 | 5 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 7.45e-04 | 203 | 19 | 3 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 7.67e-04 | 46 | 19 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_500 | 8.35e-04 | 48 | 19 | 2 | gudmap_developingGonad_e18.5_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 9.06e-04 | 50 | 19 | 2 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 1.02e-03 | 53 | 19 | 2 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 1.22e-03 | 241 | 19 | 3 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500 | 1.30e-03 | 60 | 19 | 2 | gudmap_developingGonad_e12.5_ovary_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.54e-03 | 261 | 19 | 3 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 164 | 20 | 3 | 5ee3729fab794d7acb172d14ec5d91aa1a61cd61 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.17e-05 | 174 | 20 | 3 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 178 | 20 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 179 | 20 | 3 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 179 | 20 | 3 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.06e-05 | 182 | 20 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.89e-05 | 189 | 20 | 3 | a6c62b456982067ad4d224a2efa3919969000693 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.89e-05 | 189 | 20 | 3 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.02e-05 | 190 | 20 | 3 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 191 | 20 | 3 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 8.40e-05 | 193 | 20 | 3 | f0a07bb221a497a9f7cc706045d5205269be4515 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.66e-05 | 195 | 20 | 3 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | 45d1acd316d0ced97dfb150c3a943128d8fa4e7e | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.66e-05 | 195 | 20 | 3 | b61b8c931bd0ca3678486653ae1d7e9915c696c7 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.79e-05 | 196 | 20 | 3 | 00bef0e47739932fd1da109cd607de0789d14ca5 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.79e-05 | 196 | 20 | 3 | 75e9e430a4f55ef10f2e3132afa690fc8bfaff83 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.79e-05 | 196 | 20 | 3 | cd507ee2baf4f52d6498811b3510d3164b56311f | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 8.92e-05 | 197 | 20 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | wk_15-18-Epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 12bbe77c3d68bf1e545949dbb1eb49ed3641de3d | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.19e-05 | 199 | 20 | 3 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.19e-05 | 199 | 20 | 3 | 90b20fce27739f28609d664475a197eea586e030 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.19e-05 | 199 | 20 | 3 | b8dc5dc9fe3f52be11940d45959134b2a7575a8b | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.19e-05 | 199 | 20 | 3 | bbf81fb20da8a28aac024207696c6ea00473a0df | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 9.19e-05 | 199 | 20 | 3 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.19e-05 | 199 | 20 | 3 | 617fd53c799722879acd8f2fd69b331d82e7bdb9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | Control-Myeloid-TRAM2|Control / Disease group,lineage and cell class （2021.01.30） | 9.19e-05 | 199 | 20 | 3 | 5a08184573e524ce0e2974eed9817354890830a9 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.33e-05 | 200 | 20 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.18e-04 | 95 | 20 | 2 | 74df0149882e2cd0d9aba0ef1ae4aac2cc1aeeac | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.39e-03 | 124 | 20 | 2 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.66e-03 | 136 | 20 | 2 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.66e-03 | 136 | 20 | 2 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | TCGA-Thryoid|World / Sample_Type by Project: Shred V9 | 1.71e-03 | 138 | 20 | 2 | 8cbae2ec9a51712bed5b4e5f9f834ecccb6b7a47 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-03 | 142 | 20 | 2 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-03 | 142 | 20 | 2 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-03 | 143 | 20 | 2 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_Naive|Bac-SEP / Disease, Lineage and Cell Type | 1.86e-03 | 144 | 20 | 2 | fdcf84e8b5fdc0730f243919f9cc30492e24dd75 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-03 | 144 | 20 | 2 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 1.91e-03 | 146 | 20 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.02e-03 | 150 | 20 | 2 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-03 | 151 | 20 | 2 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-03 | 153 | 20 | 2 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.15e-03 | 155 | 20 | 2 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-03 | 158 | 20 | 2 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-03 | 159 | 20 | 2 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-03 | 159 | 20 | 2 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.26e-03 | 159 | 20 | 2 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.26e-03 | 159 | 20 | 2 | 35a63ca521635389a1edc7c81157793b8ad24d38 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-03 | 162 | 20 | 2 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-03 | 162 | 20 | 2 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-03 | 162 | 20 | 2 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-03 | 162 | 20 | 2 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.37e-03 | 163 | 20 | 2 | c1a98d6776b685f20dde049715233e5c73ce3244 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-03 | 164 | 20 | 2 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 164 | 20 | 2 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 165 | 20 | 2 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-03 | 166 | 20 | 2 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | 758817f38e843db4ef6ab3e2bfb9f1a2075c9af9 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | a1211afc1197d078eb3db0d0f788ecaf4419aa5b | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.46e-03 | 166 | 20 | 2 | 021b9344de7957762f81b09a647504b8c8289cf1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.46e-03 | 166 | 20 | 2 | b60954e5625743657d0fd9264b738b46e72fd8a6 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 166 | 20 | 2 | 019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.46e-03 | 166 | 20 | 2 | fcd0bd70b553789092249806ace324b77bd10481 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-03 | 167 | 20 | 2 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-03 | 167 | 20 | 2 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-03 | 167 | 20 | 2 | f90cf0f29c14df4f211193326699e599ef955fa4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-03 | 168 | 20 | 2 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | facs-Large_Intestine-Proximal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | 23e0e1592d7400012d289adb10c7598285bae2e9 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-03 | 168 | 20 | 2 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | Immune_cells-Neutrophils|Immune_cells / Lineage and Cell class | 2.52e-03 | 168 | 20 | 2 | 3539f802fe0143da1462df0618f78f9f15143f71 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.55e-03 | 169 | 20 | 2 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.55e-03 | 169 | 20 | 2 | 5f522a10b6ec24a353f53bec2f779a81cd5f9581 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-03 | 169 | 20 | 2 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-03 | 169 | 20 | 2 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-03 | 169 | 20 | 2 | 1a47a4892a5e6a69555f5332308503526e5422a7 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-03 | 169 | 20 | 2 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.58e-03 | 170 | 20 | 2 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-03 | 170 | 20 | 2 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-03 | 170 | 20 | 2 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-03 | 170 | 20 | 2 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| Computational | Neighborhood of SMC1L1 | 6.36e-05 | 62 | 14 | 3 | MORF_SMC1L1 | |
| Computational | Neighborhood of CUL1 | 9.95e-05 | 72 | 14 | 3 | MORF_CUL1 | |
| Computational | Neighborhood of CDK2 | 9.95e-05 | 72 | 14 | 3 | MORF_CDK2 | |
| Computational | Neighborhood of XRCC5 | 1.88e-04 | 235 | 14 | 4 | MORF_XRCC5 | |
| Computational | Neighborhood of MTA1 | 2.72e-04 | 101 | 14 | 3 | MORF_MTA1 | |
| Computational | Neighborhood of RRM1 | 2.80e-04 | 102 | 14 | 3 | MORF_RRM1 | |
| Computational | Neighborhood of DEK | 2.93e-04 | 264 | 14 | 4 | MORF_DEK | |
| Computational | Neighborhood of BUB3 | 3.52e-04 | 277 | 14 | 4 | MORF_BUB3 | |
| Computational | Neighborhood of HDAC2 | 3.67e-04 | 280 | 14 | 4 | MORF_HDAC2 | |
| Computational | Neighborhood of DNMT1 | 4.30e-04 | 118 | 14 | 3 | MORF_DNMT1 | |
| Computational | Neighborhood of GNB1 | 5.08e-04 | 305 | 14 | 4 | MORF_GNB1 | |
| Computational | Neighborhood of PPP2CA | 5.58e-04 | 129 | 14 | 3 | MORF_PPP2CA | |
| Computational | Neighborhood of FBL | 7.09e-04 | 140 | 14 | 3 | MORF_FBL | |
| Computational | Neighborhood of RAD23A | 8.35e-04 | 348 | 14 | 4 | MORF_RAD23A | |
| Computational | Neighborhood of RFC4 | 8.83e-04 | 151 | 14 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of TDG | 9.15e-04 | 35 | 14 | 2 | GNF2_TDG | |
| Computational | Neighborhood of RAD21 | 1.02e-03 | 37 | 14 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of HDAC1 | 1.08e-03 | 38 | 14 | 2 | GCM_HDAC1 | |
| Computational | Neighborhood of HAT1 | 1.35e-03 | 175 | 14 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of ELAC2 | 1.58e-03 | 46 | 14 | 2 | GNF2_ELAC2 | |
| Computational | Neighborhood of PFN1 | 1.94e-03 | 51 | 14 | 2 | GCM_PFN1 | |
| Computational | Neighborhood of ACP1 | 2.31e-03 | 211 | 14 | 3 | MORF_ACP1 | |
| Computational | Neighborhood of PPP1CC | 2.33e-03 | 56 | 14 | 2 | GCM_PPP1CC | |
| Computational | Neighborhood of RAC1 | 2.34e-03 | 212 | 14 | 3 | MORF_RAC1 | |
| Computational | Neighborhood of DEK | 2.50e-03 | 58 | 14 | 2 | GNF2_DEK | |
| Computational | Neighborhood of PRKAG1 | 2.74e-03 | 224 | 14 | 3 | MORF_PRKAG1 | |
| Computational | Neighborhood of DDX5 | 3.13e-03 | 65 | 14 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of UBE2I | 3.26e-03 | 238 | 14 | 3 | MORF_UBE2I | |
| Computational | Neighborhood of RAB6A | 3.32e-03 | 67 | 14 | 2 | MORF_RAB6A | |
| Computational | Neighborhood of TERF1 | 3.32e-03 | 67 | 14 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of EIF3S2 | 3.58e-03 | 246 | 14 | 3 | MORF_EIF3S2 | |
| Computational | Neighborhood of DDB1 | 3.58e-03 | 246 | 14 | 3 | MORF_DDB1 | |
| Computational | Neighborhood of CBFB | 3.62e-03 | 70 | 14 | 2 | GCM_CBFB | |
| Computational | Neighborhood of HDAC1 | 3.91e-03 | 254 | 14 | 3 | MORF_HDAC1 | |
| Computational | Neighborhood of KPNB1 | 3.93e-03 | 73 | 14 | 2 | GNF2_KPNB1 | |
| Computational | Neighborhood of XRCC5 | 4.14e-03 | 75 | 14 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of RAN | 4.55e-03 | 268 | 14 | 3 | MORF_RAN | |
| Computational | Neighborhood of SOD1 | 5.04e-03 | 278 | 14 | 3 | MORF_SOD1 | |
| Computational | Neighborhood of PCNA | 5.05e-03 | 83 | 14 | 2 | MORF_PCNA | |
| Computational | Neighborhood of CSNK2B | 5.51e-03 | 287 | 14 | 3 | MORF_CSNK2B | |
| Computational | Neighborhood of APEX1 | 6.17e-03 | 92 | 14 | 2 | GNF2_APEX1 | |
| Computational | Neighborhood of UBE2N | 6.56e-03 | 95 | 14 | 2 | MORF_UBE2N | |
| Computational | Neighborhood of CSNK2B | 7.11e-03 | 99 | 14 | 2 | GCM_CSNK2B | |
| Computational | Neighborhood of PAPSS1 | 7.68e-03 | 103 | 14 | 2 | MORF_PAPSS1 | |
| Computational | Neighborhood of HDAC1 | 8.72e-03 | 110 | 14 | 2 | GNF2_HDAC1 | |
| Computational | Neighborhood of RAF1 | 8.87e-03 | 111 | 14 | 2 | MORF_RAF1 | |
| Computational | Neighborhood of APEX1 | 9.34e-03 | 114 | 14 | 2 | GCM_APEX1 | |
| Computational | Neighborhood of NPM1 | 9.65e-03 | 116 | 14 | 2 | GCM_NPM1 | |
| Computational | Neighborhood of ACTG1 | 1.10e-02 | 124 | 14 | 2 | GCM_ACTG1 | |
| Computational | Neighborhood of AP3D1 | 1.20e-02 | 130 | 14 | 2 | MORF_AP3D1 | |
| Computational | Neighborhood of MAP2K2 | 1.24e-02 | 132 | 14 | 2 | MORF_MAP2K2 | |
| Computational | Neighborhood of EI24 | 1.44e-02 | 143 | 14 | 2 | MORF_EI24 | |
| Computational | Neighborhood of CDC10 | 1.50e-02 | 146 | 14 | 2 | MORF_CDC10 | |
| Computational | Neighborhood of UBE2N | 1.66e-02 | 154 | 14 | 2 | GCM_UBE2N | |
| Drug | 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one | 2.63e-05 | 9 | 20 | 2 | ctd:C539142 | |
| Drug | O-desmethyltramadol | 4.01e-05 | 11 | 20 | 2 | CID000130829 | |
| Drug | glutamin | 4.02e-05 | 461 | 20 | 5 | CID000000738 | |
| Disease | MiT family translocation renal cell carcinoma | 9.15e-06 | 7 | 20 | 2 | C4518356 | |
| Disease | Sezary Syndrome | 1.52e-04 | 27 | 20 | 2 | C0036920 | |
| Disease | Diaphragmatic Hernia | 3.52e-04 | 41 | 20 | 2 | C0019284 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 5.24e-04 | 50 | 20 | 2 | C1862939 | |
| Disease | Small cell carcinoma of lung | 6.12e-04 | 54 | 20 | 2 | C0149925 | |
| Disease | Lung diseases | 1.27e-03 | 78 | 20 | 2 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMAANMSGTFGGANM | 56 | P50995 | |
| MGQMAAQMGQLGQMG | 2261 | Q92793 | |
| SRFMGPASGMNMSGM | 126 | P43699 | |
| EIRMGQMAMGGAMGI | 381 | Q15233 | |
| QMAMGGAMGINNRGA | 386 | Q15233 | |
| SAAGMGLTGTMGMGM | 586 | Q14677 | |
| GMAMAGAGVISGFDM | 311 | Q86U10 | |
| AMQKVMATTGGMGMG | 156 | P52272 | |
| MGGMEGPFGGGMENM | 346 | P52272 | |
| GMENMGRFGSGMNMG | 356 | P52272 | |
| EAGNMVMLGDGSMGD | 1691 | Q8IZD9 | |
| GQITVDMMYGGMRGM | 61 | O75390 | |
| HGSRPLQDMMGMGGM | 541 | Q86UU0 | |
| LQDMMGMGGMMVRGP | 546 | Q86UU0 | |
| GMAGSGMGQSMEMER | 696 | Q86UU0 | |
| PFGMLGMSGGFMDMF | 66 | Q15773 | |
| GMSGGFMDMFGMMND | 71 | Q15773 | |
| MNAGLGMNGMNTYMS | 31 | Q9Y261 | |
| MGSGSGNMSAGSMNM | 51 | Q9Y261 | |
| AMGGAFSSMAAAGMG | 526 | O15119 | |
| GGMGSMNSVTGGMGM | 461 | Q9P2K5 | |
| MNSVTGGMGMGLDRM | 466 | Q9P2K5 | |
| NQMKGMGMRSGGHAG | 91 | P51532 | |
| MMGQGSQGSSMMGQR | 216 | O75177 | |
| RERDMRMGGGGAMNM | 606 | P23246 | |
| PAGYMGGMQASMMGV | 336 | Q8WU79 | |
| QQMAGMNFYGANGMM | 391 | Q8WU79 | |
| AQMQMQMQGGDGDGG | 341 | Q15019 | |
| GRSGGGGLMEEMNAM | 256 | P50552 |